{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
  • Sign In
  • Home
  • Live
  • On-Demand
  • RSS/Grand Rounds
  • Non-Accredited
  • About
  • Contact Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

MD Anderson workforce members:  Select "MD ANDERSON LOGIN" and enter your MD Anderson email address and password.

Guests (all other than MD Anderson workforce members): Select "GUEST LOGIN" and enter your email address and password.

MD ANDERSON LOGIN
GUEST LOGIN
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • AA
  • AAS
  • ADN
  • BA
  • BS
  • BSN
  • DDS
  • DMD
  • DMin
  • DNP
  • DO
  • DrPH
  • DVM
  • DVM,PhD
  • EdD
  • JD
  • MA
  • MBA
  • MBBS
  • MBBS,MD
  • MD
  • MD, MBA
  • MD, MPH
  • MD, PhD
  • MDiv
  • MEd
  • MHA
  • MPA
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • Other
  • PharmD
  • PharmD, PhD
  • PhD
  • PsyD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

A Comprehensive Board Review in Hematology and Medical Oncology


LIVEMedical OncologyHematologyBoard ReviewMOC CreditsSolid Tumor
A Comprehensive Board Review in Hematology and Medical Oncology Banner

  • Overview
  • Faculty
  • Schedule
  • Brochure
Add to Calendar A Comprehensive Board Review in Hematology and Medical Oncology 10/3/2022 7:15:00 AM 10/8/2022 4:30:00 PM America/Chicago For More Details: https://mdanderson.cloud-cme.com/hmobr2022 Description: The course is designed for medical hematologists and oncologists, and other healthcare providers in the field of hematology and oncology. This course will effectively prepare participants to certify or re-certify in ABIM examinations in hematology and medical oncology and update participants in current standards of care for patients with blood disorders and malignancies. Virtual false MM/DD/YYYY


Date & Location
Monday, October 3, 2022, 7:15 AM - Saturday, October 8, 2022, 4:30 PM, Virtual

Target Audience
Specialties - General Surgery, Geriatric Medicine, Gynecologic Oncology, Maternal-Fetal Medicine, Medical Biochemical Genetics, Medical Genetics and Genomics, Medical Microbiology Pathology, Neuroradiology, Pediatric Hospital Medicine, Thoracic Surgery
Professions - Nurse - RN, Physician (MD or DO), Physician Associate, Student or Trainee

Credits
AMA PRA Category 1 Credits™ (51.00 hours), ABIM MOC Part 2 (51.00 hours), Non-Physician Attendance (51.00 hours)

Overview
The course is designed for medical hematologists and oncologists, and other healthcare providers in the field of hematology and oncology. This course will effectively prepare participants to certify or re-certify in ABIM examinations in hematology and medical oncology and update participants in current standards of care for patients with blood disorders and malignancies.

Objectives
At the conclusion of this activity, learners will be able to:

  1. Apply knowledge gained to prepare for the hematology and medical oncology subspecialty.
  2. Utilize current standards of care for patients with cancer, blood disorders and malignancies.
  3. Demonstrate proficiency of knowledge in hematology and medical oncology.
  4. Incorporate recent advances in management of hematologic and oncologic patients.
  5. Define molecular determinants of cancer risk and apply this knowledge in practice.

Registration

A Virtual Live Streaming Course

The Comprehensive Board Review in Hematology and Medical Oncology will be virtual. This program will be presented only as a live streaming course. You will receive an email from the course platform to log in and access the live course online approximately a week before the conference. 


COMPREHENSIVE PROGRAM MATERIAL AVAILABLE FOR NON-ATTENDEES

CME Credits and MOC Points are awarded only by attending the virtual course.

For more information to purchase course material click here. 

 

PRESENTATIONS:

Course syllabus will not be printed. Presentations (slides) will be available online via the course platform and Canvas. The PowerPoint presentations will be posted online as PDFs prior to the conference. You will receive an invitation email with directives to log in Canvas.

  • The Full Conference and Oncology Session will begin at 7:30 am on Monday, October 3, 2022. The Oncology Session will adjourn at 11:35 am on Friday, October 7, 2022. The full conference will adjourn at 4:25 pm on Saturday, October 8, 2022.
  • The Hematology Session will begin will begin at 7:30 am on Thursday, October 6, 2022 and adjourn at 4:25 pm on Saturday, October 8, 2022.

Advanced registration is encouraged. Please see the registration fees below.

*NOTE: The conference registration fee includes the tuition, access to course virtual platform with PDFs of the slides and Canvas - online web-based system with recorded videos.

The deadline for advanced registration is Friday, September 16, 2022.

Telephone registrations are not accepted.

We accept the following forms of payment:

  • Credit Cards (MasterCard, VISA, and American Express)
  • Check (payable through U.S. banks only)
  • Mail to: Continuing Professional Education – Unit 1781, The University of Texas MD Anderson Cancer Center, P.O. Box 301407, Houston, TX 77230-1407

Make check payable to:  The University of Texas MD Anderson Cancer Center

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form.

CONFERENCE REGISTRATION FEES

Full Conference - MDs, PhDs, DOs, PharmDs

Postmarked On Or Before August 26, 2022 - $1,200
Postmarked On Or Before September 16, 2022 - $1,300
Postmarked After September 16, 2022 - $1,400

Full Conference - Residents/Fellows/MD Anderson Alumni*

Postmarked On Or Before August 26, 2022 - $800
Postmarked On Or Before September 16, 2022 - $900
Postmarked After September 16, 2022 - $1,000
 
* A letter of introduction from the program director or chairperson with registration form is required to claim this reduced fee. 

Full Conference

Providers/Nurses/Advanced Practice Nurses* - $450
 

Full Conference

MD Anderson/Baylor Faculty/Staff - $500
MD Anderson/Baylor Clinical Fellows* - Exempt
 
* A letter of introduction from the program director or chairperson with registration form is required to claim this reduced fee. 

Oncology Session - 4 1/2 days (Monday - Friday AM) - MDs, PhDs, DOs, PharmDs
Postmarked On Or Before August 26, 2022 - $650
Postmarked On Or Before September 16, 2022 - $700
Postmarked After September 16, 2022 - $750

Oncology Session - 4 1/2 days (Monday - Friday AM) - Residents/Fellows/MD Anderson Alumni*
Postmarked On Or Before August 26, 2022 - $450
Postmarked On Or Before September 16, 2022 - $500
Postmarked After September 16, 2022 - $550
 

* A letter of introduction from the program director or chairperson with registration form is required to claim this reduced fee.



Hematology Session - 3 days (Thursday - Saturday) - MDs, PhDs, DOs, PharmDs

Postmarked On Or Before August 26, 2022 - $550
Postmarked On Or Before September 16, 2022 - $600
Postmarked After September 16, 2022 - $650

Hematology Session - 3 days (Thursday - Saturday) - Residents/Fellows/MD Anderson Alumni*
Postmarked On Or Before August 26, 2022 - $350
Postmarked On Or Before September 16, 2022 - $400
Postmarked After September 16, 2022 - $450
 
 * A letter of introduction from the program director or chairperson with registration form is required to claim this reduced fee.

REFUND/CANCELLATION POLICY

The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before Friday, September 16, 2022.  No refunds will be granted after that date.  The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check.  For additional information, contact Continuing Professional Education at 713-792-2223 or toll free at 866-849-5866.

Continuing Professional Education reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.

In case of activity cancellation, the liability of Continuing Professional Education is limited to the registration fee. Continuing Professional Education will refund the full registration fee.

Continuing Professional Education reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. Please check the website.

Please let us know what specific topics, issues, or questions you wish to see addressed or emphasized in this activity by emailing Continuing Professional Education at [email protected]. All responses will be forwarded to the Program Chairs for consideration.

SPECIAL ASSISTANCE
Contact Felisha Estelle in Continuing Professional Education at 713-745-0083 or 1-866-531-MOBR (6627) if you have any ADA accommodation needs. 

Accreditation
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 51.00 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
 MOC Points

American Board of Internal Medicine

 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 51.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. In order to receive MOC points, you must pass the post-test with a score of 70% or higher.

Participant completion data will be shared with and transmitted to the ACCME on the participant’s behalf. 


Additional Information

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 




The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.



Mitigation of Relevant Financial Relationships


The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
John M Stewart, MD
Professor
UT MDACC
CE Reviewer
Nothing to disclose
Sharon H. Giordano, MD, FASCO
Professor
The University of Texas MD Anderson Cancer Center
Co-Director, Faculty
Nothing to disclose
Tapan Kadia, MD
Professor
The University of Texas MD Anderson Cancer Center
Co-Director, Faculty
Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Pfizer Inc.|Grant or research support-AbbVie Inc.|Grant or research support-Amgen Inc.|Grant or research support-Genentech, Inc.|Grant or research support-Ascentage|Grant or research support-Cellenkos|Grant or research support-AstraZeneca US|Grant or research support-Astellas Scientific and Medical Affairs, Inc.|Paid consultant-AbbVie Inc.|Paid consultant-Genentech, Inc.|Grant or research support-Genfleet|Grant or research support-Sellas, Inc|Grant or research support-Delta Fly Pharma|Grant or research support-Jazz Pharmaceuticals|Paid consultant-Jazz Pharmaceuticals|Paid consultant-Novartis Pharmaceuticals Corporation|Paid consultant-Daiichi Sankyo, Inc.|Paid consultant-Agios Pharmaceuticals Inc.|Paid consultant-Pfizer Inc.
Martha Mims, MD, PhD
Professor and Section Chief, Hematology/Oncology
Baylor College of Medicine
Co-Director, Faculty
Stocks or stock options, excluding diversified mutual funds-Amgen Inc.|Stocks or stock options, excluding diversified mutual funds-Biogen Inc.|Other: conduct of clinical trials-Millennium Pharmaceuticals, Inc., The Takeda Oncology Company|Other: Conduct of clinical trials-Celgene Corporation|Other: Conduct of clinical trials-Incyte Corporation|Other: conduct of clinical trials-inovio (Relationship has ended)|Other: conduct of clinical trials-Aveo
Lynne V. Abruzzo, MD, PhD
Adjunct Professor of Pathology
The Ohio State University
Faculty
Nothing to disclose
Rodabe N. Amaria, MD
Associate Professor, Melanoma Medical Oncology
The University of Texas MD Anderson Cancer Center
Faculty
Grant or research support-Novartis Pharmaceuticals Corporation|Grant or research support-Merck Sharp & Dohme Corp. (any division)|Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Lovance|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis Pharmaceuticals Corporation|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Bristol-Myers Squibb Company|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Lovance|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Nektar
Kenneth Bauer, MD, Physician
Professor
Beth Israel Deaconess Medical Center
Faculty
Nothing to disclose
Nancy Berliner, MD
Chief, Division of Hematology
Brigham and Women's Hospital
Faculty
Nothing to disclose
Abenaa Brewster, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Lauren A. Byers, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Consulting Fee-Merck Sharp & Dohme Corp. (any division)|Consulting Fee-Arrowhead Pharmaceuticals|Consulting Fee-Chugai Pharmaceutical Co.|Consulting Fee-AstraZeneca US|Consulting Fee-Genentech, Inc.|Consulting Fee-BeiGene|Consulting Fee-AbbVie Inc.|Grant or research support-AstraZeneca US
Tina Cascone, MD, PhD
Assistant Professor
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Mariana C. Chavez MacGregor , MD, MSC, Associate Profesor
Associate Professor
The University of Texas MD Anderson Cancer Center
Faculty
Grant or research support-Novartis Pharmaceuticals Corporation (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Pfizer Inc. (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca US|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Genentech, Inc.|Advisor-Genomic Health, Inc. (Relationship has ended)
Kelly Chien, MD
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Jorge Cortes, MD
Director
Georgia Cancer Center at Augusta University
Faculty
Advisor-Pfizer Inc.|Advisor-Novartis Pharmaceuticals Corporation|Advisor-Millennium Pharmaceuticals, Inc., The Takeda Oncology Company|Advisor-Sun Pharma
Courtney D. Dinardo, MD
Associate Professor
The University of Texas MD Anderson Cancer Center
Faculty
Honoraria-AbbVie Inc.|Honoraria-Agios Pharmaceuticals Inc.|Honoraria-Astellas Scientific and Medical Affairs, Inc. (Relationship has ended)|Honoraria-Bristol-Myers Squibb Company|Honoraria-Celgene Corporation|Honoraria-GlaxoSmithKline|Honoraria-Jazz Pharmaceuticals|Honoraria-Novartis Pharmaceuticals Corporation (Relationship has ended)|Honoraria-Servier Pharmaceuticals
Christopher R. Flowers, MD, FASCO
Chair, Lymphoma/Myeloma, Division Head Ad Interim, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Faculty
Consulting Fee-Beigene|Consulting Fee-BioAscend (Relationship has ended)|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Curio Sciences (Relationship has ended)|Consulting Fee-Denovo Biopharma |Consulting Fee-Epizyme, Inc.|Consulting Fee-Genentech, Inc.|Consulting Fee-Foresight Diagnostics|Stocks or stock options, excluding diversified mutual funds-Foresight Diagnostics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Foresight Diagnostics|Consulting Fee-Genmab (Relationship has ended)|Consulting Fee-MorphoSys AG |Consulting Fee-Janssen Biotech, Inc. (Relationship has ended)|Consulting Fee-Seattle Genetics, Inc. (Relationship has ended)
Ravin J. Garg, MD
Medical Doctor
Maryland Oncology Hematology/US Oncology and Assistant Professor of Oncology/Johns Hopkins Hospital
Faculty
Nothing to disclose
Timothy D. Gilligan, MD, FASCO, FACH
Associate Professor & Vice-Chair for Education
Cleveland Clinic Taussig Cancer Institute
Faculty
Nothing to disclose
Betty Hamilton, MD
Cleveland Clinic
Faculty
Consulting Fee-Incyte Corporation|Consulting Fee-Angiocrine|Advisor-Equilium (Relationship has ended)|Advisor-Nkarta |Consulting Fee-Syndax (Relationship has ended)|Consulting Fee-Kadmon
Nasser H. Hanna, MD
Professor of Medicine
Indiana University
Faculty
Grant or research support-Merck Sharp & Dohme Corp. (any division)|Grant or research support-Genentech, Inc.
Matthew Heeney, MD
Associate Chief - Hematology
Boston Children's Hospital
Faculty
Consulting Fee-Pharmacosmos|Consulting Fee-Keros Therapeutics
Mimi Hu, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Grant or research support-Lilly USA, LLC|Advisor-Lilly USA, LLC (Relationship has ended)|Speakers Bureau-Veracyte (Relationship has ended)|Advisor-Blueprint Medicines Corporation (Relationship has ended)|Speakers Bureau-Targeted Oncology (Relationship has ended)
Claudine Isaacs, MD, FRCPC
Professor
Georgetown
Faculty
Consulting Fee-Genentech, Inc.|Consulting Fee-PUMA|Consulting Fee-Seattle Genetics, Inc.|Consulting Fee-AstraZeneca US|Consulting Fee-Novartis Pharmaceuticals Corporation|Consulting Fee-Pfizer Inc.|Consulting Fee-Eisai, Inc. (Relationship has ended)|Consulting Fee-Sanofi US (Relationship has ended)|Consulting Fee-ION Solutions (Relationship has ended)|Consulting Fee-Gilead Sciences, Inc.|Royalties or Patent Beneficiary-Wolters Kluwer (UpToDate)|Royalties or Patent Beneficiary-McGraw Hill (Goodman and Gillman)
Eric Jonasch, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Consulting Fee-Aveo (Relationship has ended)|Consulting Fee-aravive|Consulting Fee-calithera (Relationship has ended)|Grant or research support-arrowhead|Consulting Fee-Eisai, Inc.|Honoraria-exelixis|Honoraria-Ipsen US|Honoraria-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis Pharmaceuticals Corporation|Honoraria-Nikang|Grant or research support-Nikang|Honoraria-Takeda (Relationship has ended)|Honoraria-DAVA
Hagop M. Kantarjian, MD
Chair, Leukemia
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Scott Kopetz, MD, PhD
Professor, GI Medical Oncology
The University of Texas MD Anderson Cancer Center
Faculty
Consulting Fee-Genentech, Inc.|Consulting Fee-EMD Serono Inc.|Consulting Fee-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Consulting Fee-Holy Stone|Consulting Fee-Novartis Pharmaceuticals Corporation|Consulting Fee-Lilly USA, LLC|Consulting Fee-Boehringer Ingelheim|Consulting Fee-Boston Biomedical|Consulting Fee-AstraZeneca/MedImmune|Consulting Fee-Bayer HealthCare Pharmaceuticals, Inc.|Consulting Fee-Pierre Fabre|Consulting Fee-Redx Pharma|Consulting Fee-Ipsen US|Consulting Fee-Daiichi Sankyo, Inc.|Consulting Fee-Natera|Consulting Fee-HalioDx|Consulting Fee-Lutris|Consulting Fee-Jacobio|Consulting Fee-Pfizer Inc.|Consulting Fee-Repare|Consulting Fee-Inivata|Consulting Fee-GlaxoSmithKline|Consulting Fee-Jazz Pharmaceuticals|Consulting Fee-Iylon|Consulting Fee-Xilis|Consulting Fee-AbbVie Inc.|Consulting Fee-Amal Therapeutics|Consulting Fee-Gilead Sciences, Inc.|Consulting Fee-Mirati Therapeutics|Consulting Fee-Flame Biosciences|Consulting Fee-Servier|Consulting Fee-Carina Biotechnology|Consulting Fee-Bicara Therapeutics|Consulting Fee-Endeavor BioMedicines|Consulting Fee-Numab Pharma|Consulting Fee-Johnson & Johnson (any division)|Grant or research support-Sanofi US|Grant or research support-Biocartis|Grant or research support-Guardant Health|Grant or research support-Array Bio-Pharma|Grant or research support-Genentech/Roche|Grant or research support-EMD Serono Inc.|Grant or research support-MedImmune|Grant or research support-Novartis Pharmaceuticals Corporation|Grant or research support-Amgen Inc.|Grant or research support-Lilly USA, LLC|Grant or research support-Daiichi Sankyo
Mark Lewis, MD
Intermountain Healthcare
Faculty
Consulting Fee-Helsinn Therapeutics (U.S.) Inc. (Relationship has ended)|Speakers Bureau-AstraZeneca US|Speakers Bureau-Natera|Consulting Fee-Ipsen US (Relationship has ended)|Consulting Fee-Novartis Pharmaceuticals Corporation (Relationship has ended)|Consulting Fee-Pfizer Inc. (Relationship has ended)|Consulting Fee-Astellas Scientific and Medical Affairs, Inc. (Relationship has ended)
Whitney Lewis, PharmD
Clinical Pharmacy Specialist
The University of Texas MD Anderson Cancer Center
Faculty
Membership on Advisory Committees or Review Panels, Board Membership, etc.-Takeda (Relationship has ended)
Jennifer K. Litton, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Honoraria-UpToDate|Grant or research support-Pfizer Inc. (Relationship has ended)|Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Grant or research support-Zenith|Grant or research support-AstraZeneca US|Grant or research support-EMD Serono Inc.|Grant or research support-GlaxoSmithKline (Relationship has ended)|Grant or research support-Genentech, Inc.|Speakers Bureau-Clinical Care Options|Speakers Bureau-Medscape (Relationship has ended)|Speakers Bureau-Physician's Education Resource (Relationship has ended)|Speakers Bureau-Prime Oncology (Relationship has ended)|Speakers Bureau-Medpage
Alice Ma, MD
Professor of Medicine
University of North Carolina
Faculty
Honoraria-Baxter Healthcare Corporation
Claire Mach, PharmD
Clinical Pharmacy Specialist
Harris Health System
Faculty
Nothing to disclose
Nicholas Mitsiades, MD, PhD
University of California Davis Comprehensive Cancer Center
Faculty
Nothing to disclose
Stephan Moll, MD
UNC Chapel Hill
Faculty
Honoraria-Diagnostica Stago (Relationship has ended)
Loretta J. Nastoupil, MD
Associate Professor
The University of Texas MD Anderson Cancer Center
Faculty
Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Janssen Biotech, Inc.|Grant or research support-Genentech, Inc.|Grant or research support-Gilead Sciences, Inc.|Grant or research support-Novartis Pharmaceuticals Corporation|Grant or research support-Takeda|Honoraria-ADC Therapeutics (Relationship has ended)|Honoraria-Genmab (Relationship has ended)|Honoraria-MEI (Relationship has ended)
Kerry O'Brien, MD
Medical Director Blood Bank
Beth Israel Deaconess Medical Center
Faculty
Nothing to disclose
Susan O'Brien, MD
Professor of Medicine
University of California Irvine
Faculty
Consulting Fee-AbbVie Inc.|Consulting Fee-Regeneron Pharmaceuticals, Inc.|Consulting Fee-Pharmacyclics LLC|Consulting Fee-Pfizer Inc.|Consulting Fee-Johnson & Johnson (any division)|Consulting Fee-Janssen Biotech, Inc.|Consulting Fee-GlaxoSmithKline|Consulting Fee-Gilead Sciences, Inc.|Consulting Fee-Genentech, Inc.|Consulting Fee-Celgene Corporation|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-AstraZeneca US|Consulting Fee-Astellas Scientific and Medical Affairs, Inc.|Consulting Fee-Amgen Inc.|Consulting Fee-Alexion Pharmaceuticals, Inc.
Timothy Olson, MD, PhD
Medical Director, Blood and Marrow Transplant Program
Children's Hospital of Philadelphia
Faculty
Advisor-Vertex Pharmaceuticals (Relationship has ended)|Consulting Fee-bluebird bio|Consulting Fee-Medexus Pharmaceuticals (Relationship has ended)
Antonio Omuro, MD
Stanford University
Faculty
Grant or research support-Arcus Biosciences|Consulting Fee-Ono Pharma USA, Inc (Relationship has ended)|Consulting Fee-Pyramid (Relationship has ended)
Brian Primeaux, PharmD
Clinical Pharmacy Specialist
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Barbara Pro, MD
Columbia University Irving Medical Center
Faculty
Consulting Fee-Seattle Genetics, Inc. (Relationship has ended)
S. Vincent Rajkumar, MD
Professor of Medicine
Mayo Clinic
Faculty
Nothing to disclose
A. Koneti Rao, MD
Lewis Katz School of Medicine
Faculty
Nothing to disclose
Jose Alejandro Rauh-Hain, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Alvin H. Schmaier, MD
Robert W. Kellermeyer Professor
CASE WESTERN RESERVE UNIVERSITY
Faculty
Consulting Fee-Merck Sharp & Dohme Corp. (any division) (Relationship has ended)
Samuel A. Shelburne III, MD, Fellow Infectious Diseases Society of America
Professor, Infectious Diseases
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Arlene O. Siefker-Radtke, MD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Speakers Bureau-Janssen Biotech, Inc.|Advisor-Merck Sharp & Dohme Corp. (any division)|Advisor-Gilead Sciences, Inc.|Grant or research support-Bristol-Myers Squibb Company|Grant or research support-Janssen Biotech, Inc.|Grant or research support-Merck Research Laboratories and the Office of the Chief Medical Officer Grants|Advisor-AstraZeneca US|Advisor-Genentech, Inc.|Advisor-Bristol-Myers Squibb Company|Advisor-Seattle Genetics, Inc.|Advisor-Taiho Oncology, Inc.|Grant or research support-Basilea Pharmaceutica|Grant or research support-Millennium|Grant or research support-Nektar Therapeutics|Grant or research support-Mirati|Advisor-Bavarian Nordic|Advisor-Ideeya Immunomedics|Advisor-G1 Therapeutics
Iberia Sosa, MD, PhD
Associate Professor, Chief Hematology
Fox Chase Cancer Center
Faculty
Nothing to disclose
Sara Taveras Alam, MD
University of Texas McGovern - Memorial Hermann
Faculty
Nothing to disclose
Srdan Verstovsek, MD, PhD
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Grant or research support-Bristol-Myers Squibb Company (Relationship has ended)|Grant or research support-Constellation|Grant or research support-Galecto|Grant or research support-Geron|Grant or research support-Gilead Sciences, Inc. (Relationship has ended)|Grant or research support-Incyte Corporation|Grant or research support-Kartos|Grant or research support-PharmaEssentia|Grant or research support-Protagonist|Grant or research support-Sierra (Relationship has ended)|Grant or research support-Telios
Shannon N. Westin, MD, MPH
Professor
The University of Texas MD Anderson Cancer Center
Faculty
Grant or research support-AstraZeneca US|Consulting Fee-AstraZeneca US|Consulting Fee-Agenus (Relationship has ended)|Grant or research support-Bayer HealthCare Pharmaceuticals, Inc.|Grant or research support-Cotinga Pharmaceuticals (Relationship has ended)|Grant or research support-Clovis Oncology|Consulting Fee-Clovis Oncology|Consulting Fee-Eisai, Inc. (Relationship has ended)|Consulting Fee-EQRX (Relationship has ended)|Consulting Fee-Caris (Relationship has ended)|Grant or research support-Genentech, Inc.|Consulting Fee-Genentech, Inc. (Relationship has ended)|Consulting Fee-ImmunoGen|Grant or research support-GlaxoSmithKline|Consulting Fee-GlaxoSmithKline|Grant or research support-Jazz Pharmaceuticals|Grant or research support-Bio-Path|Grant or research support-OncXerna|Consulting Fee-Merck Sharp & Dohme Corp. (any division)|Consulting Fee-Lilly USA, LLC (Relationship has ended)|Grant or research support-Novartis Pharmaceuticals Corporation|Consulting Fee-Mersana|Grant or research support-Mereo|Consulting Fee-Mereo (Relationship has ended)|Consulting Fee-Seattle Genetics, Inc. (Relationship has ended)|Consulting Fee-Vincerx (Relationship has ended)|Grant or research support-Zentalis|Consulting Fee-Zentalis
William N. William Jr., MD
Medical Oncologist
Hospital BP
Brazil
Faculty
Consulting Fee-AstraZeneca US|Consulting Fee-Amgen Inc.|Consulting Fee-Bayer HealthCare Pharmaceuticals, Inc.|Consulting Fee-Boehringer Ingelheim|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Janssen Biotech, Inc.|Consulting Fee-Lilly USA, LLC|Consulting Fee-Merck Sharp & Dohme Corp. (any division)|Consulting Fee-Novartis Pharmaceuticals Corporation|Consulting Fee-Pfizer Inc.|Consulting Fee-Sanofi Genzyme|Consulting Fee-Genentech, Inc.
Robert A. Wolff, MD
Professor, GI Medical Oncology
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Harry H. Yoon, MD
Associate Professor
Mayo Clinic
Faculty
Grant or research support-Bristol-Myers Squibb Company|Grant or research support-CARsgen Therapeutics|Grant or research support-Macrogenics|Grant or research support-Merck Sharp & Dohme Corp. (any division)|Advisor-ALX Oncology|Advisor-AstraZeneca US|Advisor-BeiGene|Advisor-Bristol-Myers Squibb Company|Advisor-Macrogenics|Advisor-Merck Sharp & Dohme Corp. (any division)|Advisor-OncXerna|Advisor-Zymeworks|Advisor-Novartis Pharmaceuticals Corporation|Advisor-Astellas Scientific and Medical Affairs, Inc.
Felisha Estelle, BBA
CE Activity Planner
The University of Texas MD Anderson Cancer Center
Faculty, Other Planning Committee Member
Nothing to disclose
Shreyaskumar Patel, MD
Professor - Sarcoma Medical Oncology
The University of Texas MD Anderson Cancer Center
Faculty, Other Planning Committee Member
Consulting Fee-Bayer HealthCare Pharmaceuticals, Inc. (Relationship has ended)|Grant or research support-Blueprint Medicines Corporation (Relationship has ended)|Consulting Fee-Daiichi Sankyo, Inc. (Relationship has ended)|Consulting Fee-GlaxoSmithKline (Relationship has ended)
Nishin Bhadkamkar, MD
Associate Professor
The University of Texas MD Anderson Cancer Center
Other Planning Committee Member
Nothing to disclose
Alessandra Ferrajoli, MD
Professor of Medicine
The University of Texas MD Anderson Cancer Center
Other Planning Committee Member
Nothing to disclose

Monday, October 3, 2022
Virtual On-line Registration Check-in (Full Conference & Oncology Session)
6:45AM - 7:15AM
Welcome and Introduction
7:15AM - 7:30AM
Sharon H. Giordano, MD, FASCO
 
SOLID TUMOR SESSION: Breast Cancer

Screening/Local Management of Breast Cancer
7:30AM - 8:15AM
Abenaa Brewster, MD
Systemic Treatment of Primary Breast Cancer
8:15AM - 9:15AM
Sharon H. Giordano, MD, FASCO
Break
9:15AM - 9:30AM
Treatment of Metastatic Breast Cancer
9:30AM - 10:30AM
Mariana C. Chavez MacGregor , MD, MSC, Associate Profesor
Special Issues in Breast Cancer
10:30AM - 11:00AM
Jennifer K. Litton, MD
Q & A Panel Discussion
11:00AM - 11:15AM
Abenaa Brewster, MD (Panelist)
Sharon H. Giordano, MD, FASCO (Panelist)
Mariana C. Chavez MacGregor , MD, MSC, Associate Profesor (Panelist)
Jennifer K. Litton, MD (Panelist)
ASH/ASCO Choosing Wisely Recommendations
11:15AM - 11:55AM
Ravin J. Garg, MD
Lunch
11:55AM - 12:30PM
 
SOLID TUMOR SESSION: Lung Cancer/Head and Neck Cancer/Thyroid Cancer

Early Stage and Locally Advanced Non-Small Cell Lung Cancer
12:30PM - 1:15PM
Nasser H. Hanna, MD
Metastatic Non-Small Cell Lung Cancer
1:15PM - 2:15PM
Nasser H. Hanna, MD
Small Cell Lung Cancer
2:15PM - 2:45PM
Lauren A. Byers, MD
Break
2:45PM - 3:00PM
Head and Neck Cancer
3:00PM - 3:45PM
William N. William Jr., MD
Thyroid Cancer
3:45PM - 4:15PM
Mimi Hu, MD
Q & A Panel Discussion
4:15PM - 4:30PM
Nasser H. Hanna, MD (Panelist)
Lauren A. Byers, MD (Panelist)
William N. William Jr., MD (Panelist)
Mimi Hu, MD (Panelist)
Solid Tumor Q & A - Session 1: Breast Cancer/Lung Cancer/Head and Neck Cancer/Thyroid Cancer
4:30PM - 5:10PM
Tina Cascone, MD, PhD
Adjourn
5:10PM - 5:11PM
Tuesday, October 4, 2022
 
SOLID TUMOR SESSION: Genitourinary Oncology/Melanoma

Testicular Cancer
7:30AM - 8:30AM
Timothy D. Gilligan, MD, FASCO, FACH
Urothelial Cancer
8:30AM - 9:15AM
Arlene O. Siefker-Radtke, MD
Renal Cell Carcinoma
9:15AM - 10:00AM
Eric Jonasch, MD
Break
10:00AM - 10:15AM
Prostate Cancer
10:15AM - 11:30AM
Nicholas Mitsiades, MD, PhD
Melanoma
11:30AM - 12:15PM
Rodabe N. Amaria, MD
Q & A Panel Discussion
12:15PM - 12:30PM
Timothy D. Gilligan, MD, FASCO, FACH (Panelist)
Arlene O. Siefker-Radtke, MD (Panelist)
Eric Jonasch, MD (Panelist)
Nicholas Mitsiades, MD, PhD (Panelist)
Rodabe N. Amaria, MD (Panelist)
Lunch
12:30PM - 1:00PM
 
SOLID TUMOR SESSION: Neuro-Oncology/Gynecologic Oncology

Neuro-Oncology
1:00PM - 1:45PM
Antonio Omuro, MD
Cervical Cancer
1:45PM - 2:30PM
Jose Alejandro Rauh-Hain, MD
Break
2:30PM - 2:45PM
Uterine Cancer
2:45PM - 3:15PM
Shannon N. Westin, MD, MPH
Ovarian Cancer and Unusual Ovarian Histologies
3:15PM - 4:15PM
Shannon N. Westin, MD, MPH
Q & A Panel Discussion
4:15PM - 4:30PM
Antonio Omuro, MD (Panelist)
Jose Alejandro Rauh-Hain, MD (Panelist)
Shannon N. Westin, MD, MPH (Panelist)
Solid Tumor Q & A - Session 2: Genitourinary/Melanoma/Neuro-Oncology/Gyn
4:30PM - 5:10PM
Ravin J. Garg, MD
Adjourn
5:10PM - 5:11PM
Wednesday, October 5, 2022
 
SOLID TUMOR SESSION: Gastrointestinal Oncology

Pancreaticobiliary Cancers/Unknown Primary
7:30AM - 8:30AM
Robert A. Wolff, MD
Gastroesophageal Cancers/ Hepatocellular Carcinoma
8:30AM - 9:30AM
Harry H. Yoon, MD
Break
9:30AM - 9:45AM
Colorectal Cancer: Biology and Adjuvant Therapy
9:45AM - 10:15AM
Scott Kopetz, MD, PhD
Metastatic Colorectal Cancer and Anal Cancer
10:15AM - 11:15AM
Scott Kopetz, MD, PhD
Q & A Panel Discussion
11:15AM - 11:30AM
Robert A. Wolff, MD (Panelist)
Harry H. Yoon, MD (Panelist)
Scott Kopetz, MD, PhD (Panelist)
Lunch
11:30AM - 12:00PM
 
SOLID TUMOR SESSION: Sarcoma/Genetic Risk Factors/Pharmacology

Sarcoma
12:00PM - 1:00PM
Shreyaskumar Patel, MD
Genetic Risk Factors
1:00PM - 1:45PM
Claudine Isaacs, MD, FRCPC
Pharmacology I: Chemotherapy
1:45PM - 2:45PM
Claire Mach, PharmD
Break
2:45PM - 3:00PM
Pharmacology II: Targeted Therapy (Alk, EGFR, VEGR, HER2, HH, mTOR, PARP)
3:00PM - 3:30PM
Whitney Lewis, PharmD
Pharmacology III: Targeted Therapy (CD20, CD30, CD33, Proteasome, BCR-ABL/KIT, FLT3, IDH1/2, CDK4/6, PI3K)
3:30PM - 4:00PM
Brian Primeaux, PharmD
Pharmacology IV: Immunotherapy
4:00PM - 4:20PM
Claire Mach, PharmD
Q & A Panel Discussion
4:20PM - 4:35PM
Shreyaskumar Patel, MD (Panelist)
Claudine Isaacs, MD, FRCPC (Panelist)
Brian Primeaux, PharmD (Panelist)
Claire Mach, PharmD (Panelist)
Whitney Lewis, PharmD (Panelist)
Solid Tumor Q & A - Session 3: Gastrointestinal Oncology/Sarcoma/Genetic Risk Factors/Pharmacology
4:35PM - 5:15PM
Mark Lewis, MD
Adjourn
5:15PM - 5:16PM
Thursday, October 6, 2022
Virtual On-line Registration Check-in (Hematology Session)
7:00AM - 7:30AM
 
MALIGNANT HEMATOLOGY SESSION: Lymphoma/Myeloma

Classification of Lymphoma
7:30AM - 8:15AM
Lynne V. Abruzzo, MD, PhD
Aggressive Non-Hodgkin Lymphoma
8:15AM - 9:00AM
Loretta J. Nastoupil, MD
Indolent Non-Hodgkin Lymphoma
9:00AM - 9:45AM
Christopher R. Flowers, MD, FASCO
Break
9:45AM - 10:00AM
Hodgkin Lymphoma
10:00AM - 10:45AM
Barbara Pro, MD
Multiple Myeloma and Other Plasma Cell Dyscrasias
10:45AM - 11:45AM
S. Vincent Rajkumar, MD
Q & A Panel Discussion
11:45AM - 12:00PM
Lynne V. Abruzzo, MD, PhD (Panelist)
Loretta J. Nastoupil, MD (Panelist)
Christopher R. Flowers, MD, FASCO (Panelist)
Barbara Pro, MD (Panelist)
S. Vincent Rajkumar, MD (Panelist)
Lunch
12:00PM - 12:30PM
 
MALIGNANT HEMATOLOGY SESSION: Leukemia/MDS

Chronic Myeloid Leukemia
12:30PM - 1:15PM
Jorge Cortes, MD
Myelodysplastic Syndrome
1:15PM - 2:15PM
Tapan Kadia, MD
Acute Myeloid Leukemia
2:15PM - 3:00PM
Courtney D. Dinardo, MD
Break
3:00PM - 3:15PM
Acute Lymphoblastic Leukemia
3:15PM - 4:00PM
Hagop M. Kantarjian, MD
Infectious Complications in Cancer Patients
4:00PM - 4:45PM
Samuel A. Shelburne III, MD, Fellow Infectious Diseases Society of America
Q & A Panel Discussion
4:45PM - 5:00PM
Courtney D. Dinardo, MD (Panelist)
Hagop M. Kantarjian, MD (Panelist)
Tapan Kadia, MD (Panelist)
Jorge Cortes, MD (Panelist)
Samuel A. Shelburne III, MD, Fellow Infectious Diseases Society of America (Panelist)
Adjourn
5:00PM - 5:01PM
Friday, October 7, 2022
 
MALIGNANT HEMATOLOGY SESSION: MPNs/CLL/SCT

Myeloproliferative Neoplasms
7:30AM - 8:30AM
Srdan Verstovsek, MD, PhD
Charles A. Koller, MD Lectureship Award - 2022 Recipient:
8:30AM - 8:35AM
Susan O'Brien, MD
Chronic Lymphocytic Leukemia and Hairy Cell Leukemia
8:35AM - 9:15AM
Susan O'Brien, MD
Break
9:15AM - 9:35AM
Stem Cell Transplant Supportive Care
9:35AM - 10:35AM
Betty Hamilton, MD
Q & A Panel Discussion
10:35AM - 10:55AM
Betty Hamilton, MD (Panelist)
Srdan Verstovsek, MD, PhD (Panelist)
Susan O'Brien, MD (Panelist)
Malignant Hematology Q & A Session
10:55AM - 11:35AM
Kelly Chien, MD
Lunch
11:35AM - 12:15PM
 
BENIGN HEMATOLOGY SESSION: General Topics/Red Cell Disorders/Platelets

Iron Deficiency and Hemochromatosis
12:15PM - 1:00PM
Matthew Heeney, MD
Hematopoietic Growth Factors
1:00PM - 1:45PM
Martha Mims, MD, PhD
Bone Marrow Failure
1:45PM - 2:30PM
Timothy Olson, MD, PhD
Break
2:30PM - 2:45PM
Leukopenia and Leukocytosis
2:45PM - 3:30PM
Nancy Berliner, MD
Issues in Transfusion Medicine
3:30PM - 4:30PM
Kerry O'Brien, MD
Q & A Panel Discussion
4:30PM - 4:45PM
Matthew Heeney, MD (Panelist)
Timothy Olson, MD, PhD (Panelist)
Nancy Berliner, MD (Panelist)
Martha Mims, MD, PhD (Panelist)
Adjourn
4:45PM - 4:46PM
Saturday, October 8, 2022
Lunch
11:30AM - 12:00PM
 
BENIGN HEMATOLOGY SESSION: Coagulation/Platelets/Red Cell Disorders

Sickle Cell Anemias, Thalassemia, and Hemoglobinopathies
7:30AM - 8:15AM
Alice Ma, MD
Hemolytic Anemias
8:15AM - 9:00AM
Iberia Sosa, MD, PhD
Approach to Anemia
9:00AM - 9:30AM
Alice Ma, MD
Break
9:30AM - 9:45AM
Disorders of Platelet Function
9:45AM - 10:30AM
A. Koneti Rao, MD
Thrombocytopenias
10:30AM - 11:15AM
Alvin H. Schmaier, MD
Q & A Panel Discussion
11:15AM - 11:30AM
Alice Ma, MD (Panelist)
Iberia Sosa, MD, PhD (Panelist)
A. Koneti Rao, MD (Panelist)
Alvin H. Schmaier, MD (Panelist)
 
BENIGN HEMATOLOGY SESSION: Platelet/Red Cell Disorders/Transfusion Medicine

Antithrombotic & Antiplatelet Therapy
12:00PM - 12:45PM
Alvin H. Schmaier, MD
Normal Coagulation
12:45PM - 1:30PM
Kenneth Bauer, MD, Physician
Break
1:30PM - 1:45PM
Coagulation Factor Deficiencies, Including von Willebrand?s Disease and Hemophilias
1:45PM - 2:30PM
Kenneth Bauer, MD, Physician
Hypercoagulable States
2:30PM - 3:30PM
Stephan Moll, MD
Q & A Panel Discussion
3:30PM - 3:45PM
Alvin H. Schmaier, MD (Panelist)
Kenneth Bauer, MD, Physician (Panelist)
Stephan Moll, MD (Panelist)
Benign Hematology Q & A Session
3:45PM - 4:25PM
Sara Taveras Alam, MD

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Houston, TX 77030
 Privacy policies   

©2023 The University of Texas MD Anderson Cancer Center
Contact Us: [email protected]

See us on Facebook See us on Twitter See us on Linked In See us on Instagram